Analytical Data
-
Gene name
THSD7A
- Application
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q69ZU6
-
Expression Region
Thr42~Tyr242
-
Molecular Weight
27kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
THSD7A (Thrombospondin Type 1 Domain Containing 7A) is a protein that plays a crucial role in various biological processes, including cell adhesion, migration, and extracellular matrix interactions. The interest in THSD7A has grown significantly due to its involvement in certain diseases, particularly in the context of autoimmune conditions and cancer. Research has identified THSD7A as a potential autoantigen in diseases such as thrombocytopenic purpura and has linked it to the regulation of angiogenesis and tumor progression. The recombinant expression of THSD7A offers a valuable tool for elucidating its biological functions and interactions. By producing THSD7A in a controlled environment, researchers can investigate its structure-function relationships, explore its role in cellular pathways, and assess its potential as a biomarker for diagnostic purposes or as a target for therapeutic interventions. The study of THSD7A also contributes to a broader understanding of the molecular mechanisms underpinning disease pathology, making it a significant focus of ongoing biomedical research. Advances in recombinant protein technology facilitate the large-scale production of THSD7A, enabling detailed biophysical characterization and application in experimental models. Overall, the exploration of THSD7A and its recombinant protein forms holds promise for enhancing our understanding of various diseases and developing innovative therapeutic strategies.
